Wordt geladen...
Defining the right diluent for intravenous infusion of therapeutic antibodies
Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...
Bewaard in:
| Gepubliceerd in: | MAbs |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927757/ https://ncbi.nlm.nih.gov/pubmed/31774346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1685814 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|